Calidi announces offering of units, no amount given

Calidi (CLDI) Biotherapeutics announced that it intends to offer and sell, subject to market and other conditions, units consisting of shares of its common stock and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock, in an underwritten public offering. Ladenburg Thalmann & Co. is acting as sole book-running manager for the offering.